List of Papers Published This Month

Research Institute: 1. Pathology Division; 2. Biochemistry Division; 3. Chemotherapy Division; 4. Growth Factor Division; 5. Molecular Oncology Division; 6. Virology Division; 7. Genetics Division; 8. Cancer Genomics Project; 9. Cancer Prevention Basic Research Project; 10. Proteome Bioinformatics Project; 11. Early Oncogenesis Research Project; 12. President Emeritus
Research Center for Cancer Prevention and Screening: 13. Epidemiology and Prevention Division
Center for Cancer Control and Information Services: 14. Cancer Information Services and Surveillance Division

1. Pathology Division

1. Deguchi Y, Shimada K, Nara S, Esaki M, Sakamoto Y, Kosuge T, Hiraoka N. Pancreaticojejunostomy with invagination of the punched pancreatic remnant after medial pancreatectomy and enucleation for multiple metastases of renal cell carcinoma: report of a case. Surg Today, 39:1086-1090, 2009

2. Kanai Y. Genome-wide DNA methylation profiles in precancerous conditions and cancers. Cancer Sci, 101:36-45, 2010

3. Kobayashi Y, Nakanishi Y, Taniguchi H, Sekine S, Igaki H, Tachimori Y, Kato H, Matsubara H, Okazumi S, Shimoda T. Histological diversity in basaloid squamous cell carcinoma of the esophagus. Dis Esophagus, 22:231-238, 2009

4. Nakagawa T, Kanai Y, Komiyama M, Fujimoto H, Kakizoe T. Characteristics of prostate cancers found in specimens removed by radical cystoprostatectomy for bladder cancer and their relationship with serum prostate-specific antigen level. Cancer Sci, 100:1880-1884, 2009

5. Nara S, Shimada K, Sakamoto Y, Esaki M, Kosuge T, Hiraoka N. Clinical significance of frozen section analysis during resection of intraductal papillary mucinous neoplasm: should a positive pancreatic margin for adenoma or borderline lesion be resected additionally? J Am Coll Surg, 209:614-621, 2009

6. Nishiyama N, Arai E, Chihara Y, Fujimoto H, Hosoda F, Shibata T, Kondo T, Tsukamoto T, Yokoi S, Imoto I, Inazawa J, Hirohashi S, Kanai Y. Genome-wide DNA methylation profiles in urothelial carcinomas and urothelia at the precancerous stage. Cancer Sci, 101:231-240, 2010

7. Saito Y, Suzuki H, Tsugawa H, Nakagawa I, Matsuzaki J, Kanai Y, Hibi T. Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells. Oncogene, 28:2738-2744, 2009

8. Sekine S, Ogawa R, Mcmanus MT, Kanai Y, Hebrok M. Dicer is required for proper liver zonation. J Pathol, 219:365-372, 2009

2. Biochemistry Division

9. Fujiwara H, Ogino H, Maeda D, Shirai H, Nozaki T, Kamada K, Jishage K, Tanuma S, Takako T, Ochiya T, Sugimura T, Masutani M. Poly(ADP-ribose) glycohydrolase deficiency sensitizes mouse ES cells to DNA damaging agents. Curr Cancer Drug Targets, 9:953-962, 2009

10. Ichijima Y, Yoshioka K, Yoshioka Y, Shinohe K, Fujimori H, Unno J, Takagi M, Goto H, Inagaki M, Mizutani S, Teraoka H. DNA lesions induced by replication stress trigger mitotic aberration and tetraploidy development. PLoS ONE, 5:e8821, 2010

3. Chemotherapy Division

11. Matsubara J, Ono M, Yamada T. Predictive markers for chemotherapy toxicity: an important factor in personalized therapy. EJCMO, 1:1-6, 2009

4. Growth Factor Division

12. Tanaka M, Kamata R, Yanagihara K, Sakai R. Suppression of gastric cancer dissemination by ephrin-B1-derived peptide. Cancer Sci, 101:87-93, 2010

5. Molecular Oncology Division

13. Yamagata K, Kitabayashi I. Sirt1 physically interacts with Tip60 and negatively regulates Tip60-mediated acetylation of H2AX. Biochim Biophys Res Commun, 390:1355-1360, 2009

6. Virology Division

14. Yoshida K, Sugimoro N, Iwahori S, Yugawa T, Narisawa-Saito M, Kiyono T, Fujita M. CDC6 interaction with ATR regulates activation of a replication checkpoint in higher eukaryotic cells. J Cell Sci, 123:225-235, 2010

7. Genetics Division

15. Li X, Shen Y, Ichikawa H, Antes T, Goldberg GS. Regulation of miRNA expression by Src and contact normalization: effects on nonanchored cell growth and migration. Oncogene, 28:4272-4283, 2009

8. Cancer Genomics Project

16. Hasebe T, Tamura N, Okada N, Hojo T, Akashi-Tanaka S, Shimizu C, Tsuda H, Shibata T, Sasajima Y, Iwasaki M, Kinoshita T. p53 expression in tumor-stromal fibroblasts is closely associated with the nodal metastasis and outcome of patients with invasive ductal carcinoma who received neoadjuvant therapy. Hum Pathol, 41:262-270, 2010

17. Kubo T, Kuroda Y, Shimizu H, Kokubu A, Okada N, Hosoda F, Arai Y, Nakamura Y, Taniguchi H, Yanagihara K, Imoto I, Inazawa J, Hirohashi S, Shibata T. Resequencing and copy number analysis of the human tyrosine kinase gene family in poorly differentiated gastric cancer. Carcinogenesis, 30:1857-1864, 2009

9. Cancer Prevention Basic Research Project

18. Kawanishi M, Nishida H, Totsuka Y, Nishimura K, Wakabayashi K, Yagi T. Mutagenic specificity of N-nitrosotaurocholic acid in supF shuttle vector plasmids. Genes Environ, 31:9-14, 2009

19. Murakami Y, Imai N, Miura T, Sugimura T, Wakabayashi K, Totsuka Y, Hada N, Yokoyama Y, Suzuki H, Mitsunaga K. Chemical confirmation of the structure of a mutagenic aminophenylnorharman, 9-(4'-aminophenyl)-9H-pyrido[3,4-b]indole: an authentic synthesis of 9-(4'-nitrophenyl)-9H-pyrido[3,4-b]indole as its relay compound. Heterocycles, 80:455-462, 2010

20. Wakabayashi K. Chemical and biological approaches for detecting environmental causes of cancer. Genes Environ, 31:87-96, 2009

10. Proteome Bioinformatics Project

21. Harada C, Tajima H, Hirohashi S, Kondo T. Toward high performance western blotting using vacuum-driven system and laser scanner; comparison between two signal detection methods based on chemiluminescent and immunofluorescent imaging. J Electrophoresis, 53:63-66, 2009

11. Early Oncogenesis Research Project

22. Endo H, Hosono K, Fujusawa T, Takahashi H, Sugiyama M, Yoneda K, Nozaki Y, Fujita K, Yoneda M, Inamori M, Wada K, Nakagama H, Nakajima A. Involvement of JNK pathway in the promotion of the early stage of colorectal carcinogenesis under high-fat dietary conditions. Gut, 58:1637-1643, 2009

23. Li H, Okamoto K, Peart MJ, Prives C. Lysine-independent turnover of cyclin G1 can be stabilized by B'a subunits of protein phosphatase 2A. Mol Cell Biol, 29:919-928, 2009

24. Ohtsubo C, Shiokawa D, Kodama M, Gaiddon C, Nakagama H, Jochemsen AG, Taya Y, Okamoto K. Cytoplasmic tethering is involved in synergistic inhibition of p53 by Mdmx and Mdm2. Cancer Sci, 100:1291-1299, 2009

25. Sugiyama M, Takahashi H, Hosono K, Endo H, Kato S, Yoneda K, Nozaki Y, Fujita K, Yoneda M, Wada K, Nakagama H, Nakajima A. Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. Int J Oncol, 34:339-344, 2009

26. Uchida S, Yoshioka K, Kizu R, Nakagama H, Matsunaga T, Ishizaka Y, Poon RYC, Yamashita K. Stress-activated mitogen-activated protein kinases c-Jun NH₂-terminal kinase and p38 target Cdc25B for degradation. Cancer Res, 69:6438-6444, 2009

12. President Emeritus

27. Sugimura T. Obituary: Takahashi Tsuruo. Mol Cancer Ther, 8:989-990, 2009

13. Epidemiology and Prevention Division

28. Goto M, Shinmura K, Igarashi H, Kobayashi M, Konno H, Yamada H, Iwaizumi M, Kageyama S, Tsuneyoshi T, Tsugane S, Sugimura H. Altered expression of the human base excision repair gene NTH1 in gastric cancer. Carcinogenesis, 30:1345-1352, 2009

29. Goto M, Shinmura K, Tao H, Tsugane S, Sugimura H. Three novel genetic polymorphisms in the promoter region of the human base excision repair gene NEIL1 in gastric cancer patients. World J Gastrointest Oncol, 1, 2009

30. Honjo K, Iso H, Ikeda A, Inoue M, Tsugane S, the JPHC Study Group. Education level and physical functional limitations among Japanese community residents-gender difference in prognosis from stroke. BMC Public Health, 9:131, 2009

31. Ikeda A, Iso H, Kawachi I, Yamagishi K, Inoue M, Tsugane S, the JPHC Study Group. Living arrangement and coronary heart disease: the JPHC study. Heart, 95:577-583, 2009

32. Kobayashi M, Otani T, Iwasaki M, Natsukawa S, Shaura K, Koizumi Y, Kasuga Y, Sakamoto H, Yoshida T, Tsugane S. Association between dietary heterocyclic amine levels, genetic polymorphisms of NAT2, CYP1A1, and CYP1A2 and risk of stomach cancer: a hospital-based case-control study in Japan. Gastric Cancer, 12:198-205, 2009

33. Ma E, Iwasaki M, Ishihara J, Hamada GS, Nishimoto IN, Carvalho SMT, Motola JJ, Laginha FM, Tsugane S. Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Brazilian women. BMC Cancer, 9:122, 2009

34. Saito I, Konishi M, Iso H, Inoue M, Tsugane S. Impact of weight change on specific-cause mortality among middle-aged Japanese individuals. J Epidemiol Community Health, 63:447-454, 2009

35. Sharma S, Iwasaki M, Kunieda C, Cao X, Ishihara J, Hamada G, Miyajima NT, Tsugane S, Le Marchand L. Development of a quantitative food frequency questionnaire for assessing food, nutrient, and heterocyclic aromatic amines intake in Japanese Brazilians for a colorectal adenoma case-control study. Int J Food Sci Nutr, 60:128-139, 2009

14. Cancer Information Services and Surveillance Division

36. Boku N, Yamamoto S, Fukuda H, Shirao K, Doi T, Sawaki A, Koizumi W, Saito H, Yamaguchi K, Takiuchi H, Nasu J, Ohtsu A, Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study. Lancet Oncol, 10:1063-1069, 2009

37. Higashi T, Hirabayashi Y. Comparison of time trends in uterine cancer incidence (1973-2002) in Asia, from Cancer Incidence in Five Continents, Vols IV-IX. Jpn J Clin Oncol, 39:337-338, 2009

38. Hirabayashi Y, Marugame T. Comparison of time trends in ovary cancer mortality (1990-2006) in the world, from the WHO mortality database. Jpn J Clin Oncol, 39:860-861, 2009

39. Hirabayashi Y, Zhang M. Comparison of time trends in breast cancer incidence (1973-2002) in Asia, from cancer incidence in five continents, Vols IV-IX. Jpn J Clin Oncol, 39:411-412, 2009

40. Katanoda K, Yako-Suketomo H. Comparison of time trends in stomach cancer incidence (1973-2002) in Asia, from Cancer Incidence in Five Continents, Vols IV-IX. J Clin Oncol, 39:71-72, 2009

41. Marugame T, Hirabayashi Y. Comparison of time trends in lung cancer mortality (1990-2006) in the world, from the WHO mortality database. Jpn J Clin Oncol, 39:696-697, 2009

42. Marugame T, Matsuda T. Comparison of time trends in lung cancer incidence (1973-2002) in Asia, from cancer incidence in five continents Vols IV-IX. Jpn J Clin Oncol, 39:133-135, 2009

43. Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T, the Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2003: based on data from 13 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project. Jpn J Clin Oncol, 39:850-858, 2009

44. Matsuda T, Saika K. Comparison of time trends in prostate cancer incidence (1973-2002) in Asia, from cancer incidence in five continents, Vols IV-IX. Jpn J Clin Oncol, 39:468-469, 2009

45. Matsuda T, Zhang M. Comparison of time trends in colorectal cancer mortality (1990-2006) in the world, from the WHO mortality database. Jpn J Clin Oncol, 39:777-778, 2009

46. Okusaka T, Kasugai H, Shioyama Y, Tanaka K, Kudo M, Saisho H, Osaki Y, Sata M, Fujiyama S, Kumada T, Sato K, Yamamoto S, Hinotsu S, Sato T. Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: a randomized phase III trial. Hepatology, 51:1030-1036, 2009

47. Qiu D, Katanoda K, Marugame T, Sobue T. A Joinpoint regression analysis of long-term trends in cancer mortality in Japan (1958-2004). Int J Cancer, 124:443-448, 2009

48. Saika K, Matsuda T. Comparison of time trends in cancer mortality (1990-2006) in the world, from the WHO mortality database. Jpn J Clin Oncol, 39:541-542, 2009

49. Tanai C, Nokihara H, Yamamoo S, Kunitoh H, Yamamoto N, Sekine I, Ohe Y, Tamura T. Characteristics and outcomes of patients with advanced non-small-cell lung cancer who declined to participate in randomised clinical chemotherapy trials. Br J Cancer, 100:1037-1042, 2009

50. Yako-Suketomo H, Katanoda K. Comparison of time trends in stomach cancer mortality (1990-2006) in the world, from the WHO mortality database. Jpn J Clin Oncol, 39:622-623, 2009

51. Yako-Sukemoto H, Marugame T. Comparison of time trends in colon, rectum and anus cancer incidence (1973-2002) in Asia, from Cancer Incidence in Five Continents, Vols IV-IX. Jpn J Clin Oncol, 39:196-198, 2009

52. Yoshikawa T, Sasako M, Yamamoto S, Sano T, Imamura H, Fujitani K, Oshita H, Ito S, Kawashima Y, Fukushima N. Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer. Br J Surg, 96:1015-1022, 2009

53. Zhang M, Higashi T. Time trends of liver cancer incidence (1973-2002) in Asia, from cancer incidence in five continents, Vols IV-IX. Jpn J Clin Oncol, 39:275-276, 2009

Back to NCC entry point

Last Update: 100218, contact